RP and the PI in the TNBC trial who is the CTC exp

RP and the PI in the TNBC trial who is the CTC expert, Dr. Massimo Cristofanill, go back quiet a ways. They created a plan which has taken years to reach this point, the first TNBC trial with the Ccr5 inhibitor Leronlimab using CTC numbers as a gauge for progress.

http://blogs.jefferson.edu/atjeff/2013/02/12/...anilli-md/

And patent application together in 2016

https://patents.google.com/patent/WO2016209926A1/en